Status:
TERMINATED
Micro-RNA Expression Profiles in High Risk Prostate Cancer
Lead Sponsor:
Wuerzburg University Hospital
Collaborating Sponsors:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Prostate Cancer
Radical Prostatectomy
Eligibility:
MALE
35-80 years
Brief Summary
The purpose of this study is to determine whether specific Micro-RNA expression profiles are related to Prostate cancer outcome.
Eligibility Criteria
Inclusion
- Patients with clinically localised high risk prostate cancer (cT\>2, bx GS \>7, PSA \>20 ng/ml) scheduled for radical prostatectomy.
Exclusion
- Non high risk prostate cancer
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01220427
Start Date
June 1 2007
Last Update
March 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology and Pediatric Urology University Hospital Würzburg
Würzburg, Germany, 97080